DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cantil (Mepenzolate Bromide) - Summary

 



CANTIL SUMMARY

CANTIL tablets for oral administration contain 25 mg mepenzolate bromide USP.

CANTIL is indicated for use as adjunctive therapy in the treatment of peptic ulcer. It has not been shown to be effective in contributing to the healing of peptic ulcer, decreasing the rate of recurrence, or preventing complications.


See all indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Cantil (Mepenzolate Bromide)

Health Tip: Preventing a Peptic Ulcer
Source: MedicineNet Peptic Ulcer Specialty [2009.08.28]
Title: Health Tip: Preventing a Peptic Ulcer
Category: Health News
Created: 8/28/2009 8:10:00 AM
Last Editorial Review: 8/28/2009

Health Tip: Warning Signs of Peptic Ulcer
Source: MedicineNet Helicobacter Pylori Specialty [2009.03.30]
Title: Health Tip: Warning Signs of Peptic Ulcer
Category: Health News
Created: 3/28/2009 2:00:00 AM
Last Editorial Review: 3/30/2009

Peptic Ulcer
Source: MedicineNet Bernard-Soulier Disease Specialty [2005.08.31]
Title: Peptic Ulcer
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 8/31/2005

Vardenafil: A Potential Drug To Protect Gastric Mucosa
Source: Health News from Medical News Today [2009.11.19]
Indomethacin has been proved by epidemiological and experimental studies to be closely associated with peptic ulcer development. Vardenafil is a potent phosphodiesterase 5 inhibitor and its effects on the gastric mucosa have not been reported. A research article published in the World Journal of Gastroenterology addresses this problem. The research team, led by Dr.


more news >>

Page last updated: 2009-11-19

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009